White House Releases Executive Orders Aimed at Addressing High Drug Prices

September 14, 2020

President Trump yesterday signed an additional executive order aimed at lowering the price of prescription drugs. Three executive orders were signed in July seeking to do the same. Yesterday’s order directs the Secretary of Health and Human Services (HHS) to test a “most-favored-nation” pricing model for Part B, and some Part D, drugs. View highlights under key resources. 

 

Sign In to Download the Special Bulletin:
White House Releases Executive Orders Aimed at Addressing High Drug Prices

Related Resources

Action Alert
Member
In response to recent actions taken by a number of drug companies to limit the distribution of certain 340B drugs to hospitals and health systems, Reps. Diana…
Letter/Comment
Public
AHA to HHS again expressing concern with recent actions taken by several major drug manufacturers to limit the distribution of certain 340B drugs to our…
Letter/Comment
Public
AHA expresses concern regarding recent action taken by three major drug manufacturers – Eli Lilly and Co., Merck and Sanofi – to limit the distribution of…
Special Bulletin
Public
President Trump today signed three executive orders aimed at lowering the price of prescription drugs. The first executive order seeks to pass federally-…
Letter/Comment
July 20, 2020 The Honorable Seema Verma Administrator Centers for Medicare & Medicaid Services Hubert H. Humphrey Building 200 Independence Avenue, S.W.,…
Special Bulletin
Public
Download the Special Bulletin: CMS Releases Proposed Rule on Medicaid Drug Value-based Purchasing Arrangements   The Centers for Medicare &…